Literature DB >> 8838578

Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease.

Y Harigaya1, M Shoji, T Shirao, S Hirai.   

Abstract

The actin-binding protein drebrin is localized in postsynaptic terminals in adult brain and is considered to be related to synaptic plasticity. Immunocytochemical study demonstrated that widespread drebrin immunoreactivity was observed in hippocampal formations of control human brains, while Alzheimer's disease (AD) brains showed remarkable reductions in this immunoreactivity. Western blot analysis demonstrated that drebrin E (116kD) as well as drebrin A (125 kD) presented in adult human brains, and that these isoforms were decreased in parallel in AD brains. On the other hand, synaptic vesicle-specific 38-kD protein (SVP-38), a presynaptic marker was not so changed in AD brains in comparison with control brains by both techniques. These findings suggest that drebrin E and A in the adult human brain may be co-localized in postsynaptic terminals, and that drebrin may be more sensitive as a marker of synaptic damage than SVP-38, and that the disappearance of drebrin may contribute to the pathogenesis of memory disturbance in AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838578     DOI: 10.1002/jnr.490430111

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  64 in total

Review 1.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.

Authors:  Peter Penzes; Jon-Eric Vanleeuwen
Journal:  Brain Res Rev       Date:  2011-01-26

2.  Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression.

Authors:  Norihisa Ooe; Koichi Saito; Nobuyoshi Mikami; Iwao Nakatuka; Hideo Kaneko
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

3.  Role of RanBP9 on amyloidogenic processing of APP and synaptic protein levels in the mouse brain.

Authors:  Madepalli K Lakshmana; Crystal D Hayes; Steven P Bennett; Elisabetta Bianchi; Konda M Reddy; Edward H Koo; David E Kang
Journal:  FASEB J       Date:  2012-01-31       Impact factor: 5.191

4.  Accelerators, Brakes, and Gears of Actin Dynamics in Dendritic Spines.

Authors:  Crystal G Pontrello; Iryna M Ethell
Journal:  Open Neurosci J       Date:  2009-01-01

5.  Hippocampal drebrin loss in mild cognitive impairment.

Authors:  Scott E Counts; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Elliott J Mufson
Journal:  Neurodegener Dis       Date:  2012-02-04       Impact factor: 2.977

Review 6.  Neuroinflammation and synaptic loss.

Authors:  Jagadeesh S Rao; Matthew Kellom; Hyung-Wook Kim; Stanley I Rapoport; Edmund A Reese
Journal:  Neurochem Res       Date:  2012-02-07       Impact factor: 3.996

7.  Role of drebrin A in dendritic spine plasticity and synaptic function: Implications in neurological disorders.

Authors:  Anton Ivanov; Monique Esclapez; Lotfi Ferhat
Journal:  Commun Integr Biol       Date:  2009-05

8.  In vivo, competitive blockade of N-methyl-D-aspartate receptors induces rapid changes in filamentous actin and drebrin A distributions within dendritic spines of adult rat cortex.

Authors:  S Fujisawa; T Shirao; C Aoki
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

9.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

10.  Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model.

Authors:  Frédéric Calon; Giselle P Lim; Fusheng Yang; Takashi Morihara; Bruce Teter; Oliver Ubeda; Phillippe Rostaing; Antoine Triller; Norman Salem; Karen H Ashe; Sally A Frautschy; Greg M Cole
Journal:  Neuron       Date:  2004-09-02       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.